Results of the COLCOT trial - Dr. Jean-Claude Tardif

Jean-Claude Tardif, MD, principal investigator of the COLchicine Cardiovascular Outcomes Trial (COLCOT), explains what researchers found when comparing colchicine with a placebo in patients with a recent myocardial infarction.
Dr. Tardif is from the Montreal Heart Institute in Quebec, Canada.

#AHA19,American Heart Association,COLCOT,ischemic cardiovascular outcomes,heart attack treatment,